Aptevo Therapeutics Inc (NQ: APVO )

34.71 USD +1.16 (+3.46%)

Official Closing Price Updated: 7:58 PM EST, Jan 25, 2021 Add to My Watchlist

Price and Volume

Volume	108,800
Open	33.55
Bid (Size)	34.21 (1)
Ask (Size)	36.50 (1)
Prev. Close	33.55
Today's Range	32.20 - 35.00
52wk Range	0.2103 - 60.00
Shares Outstanding	22,586,132
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial

January 11, 2021

Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442

December 02, 2020

Performance

YTD	-6.64%	-6.64%
1 Month	+1.43%	+1.43%
3 Month	+397.99%	+397.99%
6 Month	+305.49%	+305.49%
1 Year	+5409.52%	+5409.52%

More News

Aptevo Confirms Receipt of Unsolicited Indication of Interest

November 19, 2020

Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical development

November 16, 2020

Aptevo Therapeutics is Now Oversold (APVO)

January 19, 2021

Aptevo Therapeutics and Alligator Bioscience Advancing the Bispecific 4-1BBx5T4 Antibody ALG.APV-527 Into Phase 1 Clinical Development

November 16, 2020

Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients

November 16, 2020

RSI Alert: Aptevo Therapeutics (APVO) Now Oversold

December 29, 2020

Mid-Afternoon Market Update: Dow Turns Positive; Medigus Shares Spike Higher

November 19, 2020

12 Healthcare Stocks Moving In Thursday's Intraday Session

November 19, 2020

Mid-Day Market Update: Nasdaq Rises 50 Points; MeiraGTx Shares Plunge

November 19, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.